Large TRV holder plans 16,712-share sale (NYSE: TRV)
Rhea-AI Filing Summary
A holder of common stock in TRV has filed a notice of proposed sale under Rule 144. The filing covers 16,712 common shares to be sold through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $4,675,593.46. The filing notes that 223,063,417 shares of this class were outstanding at the time referenced.
The shares to be sold were recently acquired by exercising stock options granted on 02/06/2018 and 02/04/2020, resulting in acquisitions of 4,912 and 11,800 shares, respectively, both paid in cash on 01/23/2026. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does this Form 144 filing for TRV disclose?
The Form 144 filing for TRV discloses that a holder of the companys common stock intends to sell 16,712 shares on the NYSE through Fidelity Brokerage Services LLC under Rule 144.
How many TRV shares are planned to be sold and what is their market value?
The notice covers a proposed sale of 16,712 common shares of TRV with an indicated aggregate market value of $4,675,593.46, based on the figures in the filing.
How were the TRV shares in this Form 144 recently acquired?
The shares were acquired by exercising stock options granted on 02/06/2018 and 02/04/2020, resulting in 4,912 and 11,800 shares, respectively, both paid for in cash on 01/23/2026.
How many TRV common shares were outstanding as referenced in the filing?
The filing states that there were 223,063,417 common shares outstanding for the issuer at the time referenced in the notice.
Which broker and exchange are involved in this planned TRV share sale?
The planned sale is to be executed through Fidelity Brokerage Services LLC, with the common shares to be sold on the NYSE.
What representation does the seller make in this TRV Form 144?
The person for whose account the securities are to be sold represents that they do not know of any material adverse information about the issuers current or prospective operations that has not been publicly disclosed.